The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation
Immunity · 2024-08 · 57 (8) · 1812-1827.e7
DOI: 10.1016/j.immuni.2024.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2024-08. Verfasst von Munesh K Harioudh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Microbiology and…. Hauptthemen laut MEDLINE: 2',5'-Oligoadenylate Synthetase, Interferon Regulatory Factor-1, Immunity, Innate. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
An important property of the host innate immune response during microbial infection is its ability to control the expression of antimicrobial effector proteins, but how this occurs post-transcriptionally is not well defined. Here, we describe a critical antibacterial role for the classic antiviral gene 2'-5'-oligoadenylate synthetase 1 (OAS1). Human OAS1 and its mouse ortholog, Oas1b, are induced by interferon-γ and protect against cytosolic bacterial pathogens such as Francisella novicida and Listeria monocytogenes in vitro and in vivo. Proteomic and transcriptomic analysis showed reduced IRF1 protein expression in OAS1-deficient cells. Mechanistically, OAS1 binds and localizes IRF1 mRNA to the rough endoplasmic reticulum (ER)-Golgi endomembranes, licensing effective translation of IRF1 mRNA without affecting its transcription or decay. OAS1-dependent translation of IRF1 leads to the enhanced expression of antibacterial effectors, such as GBPs, which restrict intracellular bacteria. These findings uncover a noncanonical function of OAS1 in antibacterial innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pitt…
- Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.
- Department of Biochemistry, Ludwig Maximilians Universität, Munich, Germany.
- Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Departments of Medicine, Molecular Microbiology, Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Immunology, UConn Health School of Medicine, Farmington, CT, USA.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Merck
- Oregon Academy of Science
- Vir Biotechnology
Zitieren
APA
Harioudh, M. K., Perez, J., So, L., Maheshwari, M., Ebert, T. S., Hornung, V., Savan, R., Rouf Banday, A., Diamond, M. S., Rathinam, V. A., & Sarkar, S. N. (2024). The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation. Immunity, 57(8), 1812-1827.e7. https://doi.org/10.1016/j.immuni.2024.06.003
Vancouver
Harioudh MK, Perez J, So L, Maheshwari M, Ebert TS, Hornung V, et al. The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation. Immunity. 2024;57(8):1812-1827.e7. doi:10.1016/j.immuni.2024.06.003
BibTeX
@article{Harioudh2024,
author = {Harioudh, Munesh K and Perez, Joseph and So, Lomon and Maheshwari, Mayank and Ebert, Thomas S and Hornung, Veit and Savan, Ram and Rouf Banday, A and Diamond, Michael S and Rathinam, Vijay A and Sarkar, Saumendra N},
title = {The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation},
journal = {Immunity},
year = {2024},
volume = {57},
number = {8},
pages = {1812--1827.e7},
doi = {10.1016/j.immuni.2024.06.003}
}
EUVIMED